The expression of the α-melanocyte stimulating hormone (α-MSH) and melanocortin-1 receptor (MC1R) in the epidermis of the vitiligo

Korean Journal of Dermatology

Volumn 41, Issue 6, 2003, Pages 690-695

  Cha, Young Chang ^a   Lee, Hyun Joo ^a   Lee, Seok Jong ^a   Na, Gun Yoen ^a   Chung, Sang Lip ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

MSH; MC1R; Vitiligo

Indexed keywords

ALPHA INTERMEDIN; CELL SURFACE RECEPTOR; IMMUNOMODULATING AGENT; MELANOCORTIN 1 RECEPTOR; PROOPIOMELANOCORTIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTEGUMENT; KERATINOCYTE; MALE; MELANOCYTE; PROTEIN EXPRESSION; PUNCH BIOPSY; SKIN CELL; SKIN DEFECT; SKIN PIGMENTATION; VITILIGO;

EID: 0041376686     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Castanet J, Ortonne JP. Pathophysiology of vitiligo. Clin Dermatol 1997;15:845-851
2. Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y. Hypomelanoses and hypermelanoses, In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB., editor. Dermatology in general medicine. 5th ed. New York: McGraw-Hill 1999:954-956
3. Bystryn JC. Serum antibodies in vitiligo patients. Clin Dermatol 1989;2:136-145
4. Thomas AL, Thomas S, Stephan G. The role of α-melanocyte stimulating hormone in cutaneous biology. J Invest Dermatol 1997;2:87-93
5. Zalfa AM, Cathy S, Itaru S, Akihiro T, Sungbin I, Lynn L et al. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res 2000;13:156-162
6. Zalfa A, Itaru S, Akihiro T, Sungbin I, Can A. The melanocortin-1 receptor and human pigmentation. Ann N Y Acad Sci 1999;885:117-133
7. Bohn M, Metze D, Schulte U, Becher E, Luger TA, Brzoska T. Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ. Exp Dermatol 1999;8:453-461
8. Silvia M, Adelina S, Lauretta A, Giuseppe H, Isabella G, Massimo F et al. New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 2002;15:87-92
9. Thody AJ, Ridley K, Penny RJ, Chalmers R, Fisher C, Shuster S. MSH peptides are present in mammalian skin. Peptides 1983 Nov-Dec;4(6):813-6
10. Luger TA, Scholzen T, Grabbe S. The role of alpha-melanocyte-stimulating hormone in cutaneous biology. J Investig Dermatol Symp Proc 1997 Aug;2(1):87-93
11. Neil FB, David LD, Rachel EI, Anne R, Wei C, Lyn RG et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 2001;116:224-229
12. Cornelis K, Jeanet TH, Marjo B, Nelleke G, Maarten B, Bergman W. et al. Melanocortin-1 receptor(MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001;117:294-300
13. Chakraborty AK, Funasaka Y, Pawelek JM, Nagahama M, Ito A, Ichihashi M. Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J Invest Dermatol 1999 Jun;112(6):853-60
14. Graham A, Westerhof W, Thody AJ. The expression of alpha-MSH by melanocytes is reduced in vitiligo. Ann N Y Acad Sci 1999;885:470-3
15. Stander S, Bohm M, Brzoska T, Zimmer KP, Luger T, Metze D. Expression of melanocortin-1 receptor in normal, malformed and neoplastic skin glands and hair follicles. Exp Dermatol 2002 Feb;11(1):42-51
16. IM S, Kim J, On WY, Kang WH. Increased expression of α-melanocyte-stimulating hormone in the lesional skin of melasma. Br J Dermatol 2002;146:165-167